Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,259
Closed -$690K 1071
2025
Q4
$690K Sell
9,259
-2,312
-20% -$169K 0.03% 425
2025
Q3
$781K Sell
11,571
-1,830
-14% -$121K 0.03% 405
2025
Q2
$873K Sell
13,401
-2,113
-14% -$127K 0.03% 347
2025
Q1
$958K Buy
+15,514
New +$1.03M 0.04% 313

Other funds holding HOLX

VestGen Advisors's HOLX Position: Q1 2026 in Review

VestGen Advisors sold out of Hologic (HOLX) in Q1 2026, closing a stake of 9,259 shares — an estimated $690K sold.

VestGen Advisors first reported a position in HOLX in Q1 2025 and held it in 4 quarters. The position peaked at $958K in Q1 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • VestGen Advisors reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • VestGen Advisors sold 9,259 Hologic shares in Q1 2026, an estimated $690K.
  • VestGen Advisors first reported a position in Hologic in Q1 2025 and held it in 4 quarters.
  • VestGen Advisors's Hologic position peaked at $958K in Q1 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on VestGen Advisors's 13F filing for Q1 2026, filed 14 May 2026.